Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Nium Launches Dual-Network Stablecoin Card Issuance Platform

New platform aims to streamline stablecoin card issuance and enhance user experience.Highlights: Nium unveils a new platform for...

Wise Launches UK Current Accounts, Expanding Financial Services

The new accounts aim to simplify banking for UK customers.Highlights: Wise introduces current accounts to UK market.The new...

Lloyds Bank Strengthens Research on AI Impact in Software Engineering

The collaboration aims to explore the future of technology in banking.Highlights: Lloyds Bank partners with the University of...

Valt Bank Secures De Novo Bank Charter, Expanding Banking Options

New bank charter enables Valt Bank to offer innovative financial services.Highlights: Valt Bank has been granted its de...